// App-Quantinova.ai

126 : HLA Cw12 in Kidney Transplant Recipients is a Novel Risk Factor for the Development of Post-Transplantation Diabetes: A Single-Centre Retrospective Study

Researchers

Presenter

  • N. Phagura

Principal Investigators

  • A. Culliford

  • F. Evison

  • S. Gallier

  • J. Nath

  • D. Briggs

  • A. Sharif

Medical Centers

  • Department of Nephrology and Transplantation, University Hospitals Birmingham, Birmingham, United Kingdom

  • Department of Dermatology, University Hospital Birmingham, Birmingham, United Kingdom

  • H&I Birmingham, NHS Blood and Transplant, Birmingham, Birmingham, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Autoimmune (AI)

Disease

  • Post-transplant diabetes mellitus

Biomarkers

  • N/A

Drug/Treatment

  • Mycophenolate mofetil

  • CKD-4101

  • Basiliximab

  • Tacrolimus

Outcome

  • N/A

Study Design

  • Multinational

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved